Showing results (321-330 of 373) with videos related to
Sort By:
Pageof 38
Cancer Research|January 15, 1994
Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancerY J Guo, G Liu, X Wang, et al.Cellular Immunology|March 1, 1994
Disruption of T lymphocyte reappearance in anti-Thy-1-treated animals in vivo with soluble CD44 and L-selectin moleculesY J Guo, J H Wong, S C Lin, et al.The Journal of Biological Chemistry|March 29, 2001
Prp-c and Prp-Sc at the fetal-maternal interfaceW Tuo, D Zhuang, D P Knowles, et al.Cellular Immunology|October 15, 1989
Defective signal transduction in CD4-CD8- T cells of lpr miceF Stafford-Brady, E Sugiyama, D R Robinson, et al.Cancer Research|March 15, 1994
Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibodyY Guo, J Ma, J Wang, et al.Science (New York, N.Y.)|January 28, 1994
Effective tumor vaccine generated by fusion of hepatoma cells with activated B cellsY Guo, M Wu, H Chen, et al.Clinical Immunology and Immunopathology|November 1, 1984
Monoclonal antibodies to tissue-specific cell surface antigens. I. Characterization of an antibody to a prostate tissue antigenA M Carroll, M Zalutsky, S Schatten, et al.International Journal of Immunopharmacology|January 1, 1987
The pharmacokinetics and toxicity of murine monoclonal antibodies and of gelonin conjugates of these antibodiesC F Scott, J M Lambert, V S Goldmacher, et al.Clinical Immunology and Immunopathology|November 1, 1983
Molecular signals in antigen presentation. I. Effects of interleukin 1 and 2 on radiation-treated antigen-presenting cells in vivo and in vitroA Tominaga, S Lefort, S B Mizel, et al.The American Journal of Pathology|August 10, 2000
Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brainS Capellari, P Parchi, C M Russo, et al.Pageof 38